OIL.AX
Price:
$0.16
Market Cap:
$133.65M
Optiscan Imaging Limited develops and commercializes confocal microscopes for clinical and pre-clinical applications in Australia, Germany, and Internationally. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes use for clinical, translational, pre-clinical, and other research. The company also engages in the development of InVivage device for use in cancer screening and surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.[Read more]
Industry
Hardware, Equipment & Parts
IPO Date
1997-09-01
Stock Exchange
ASX
Ticker
OIL.AX
According to Optiscan Imaging Limited’s latest financial reports and current stock price. The company's current ROE is -40.05%. This represents a change of 5.04% compared to the average of -38.13% of the last 4 quarters.
The mean historical ROE of Optiscan Imaging Limited over the last ten years is 26.58%. The current -40.05% ROE has changed -250.70% with respect to the historical average. Over the past ten years (40 quarters), OIL.AX's ROE was at its highest in in the December 2013 quarter at 863.75%. The ROE was at its lowest in in the December 2014 quarter at -2136.70%.
Average
26.58%
Median
-63.89%
Minimum
-176.71%
Maximum
796.41%
Discovering the peaks and valleys of Optiscan Imaging Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 208.48%
Maximum Annual ROE = 796.41%
Minimum Annual Increase = -199.08%
Minimum Annual ROE = -176.71%
Year | ROE | Change |
---|---|---|
2024 | -43.70% | -69.42% |
2023 | -142.93% | 122.60% |
2022 | -64.21% | 208.48% |
2021 | -20.82% | -81.74% |
2020 | -114.02% | 37.35% |
2019 | -83.01% | 30.57% |
2018 | -63.58% | -64.02% |
2017 | -176.71% | -199.08% |
2016 | 178.36% | -77.60% |
2015 | 796.41% | 3.74% |
The current ROE of Optiscan Imaging Limited (OIL.AX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-83.62%
5-year avg
-77.14%
10-year avg
26.58%
Optiscan Imaging Limited’s ROE is greater than Compumedics Limited (-2.75%), less than Resonance Health Limited (1.63%), greater than IDT Australia Limited (-23.28%), greater than Patrys Limited (-83.38%), greater than Uscom Limited (-79.62%),
Company | ROE | Market cap |
---|---|---|
-2.75% | $48.70M | |
1.63% | $23.90M | |
-23.28% | $46.49M | |
-83.38% | $6.17M | |
-79.62% | $7.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Optiscan Imaging Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Optiscan Imaging Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Optiscan Imaging Limited's ROE?
How is the ROE calculated for Optiscan Imaging Limited (OIL.AX)?
What is the highest ROE for Optiscan Imaging Limited (OIL.AX)?
What is the 3-year average ROE for Optiscan Imaging Limited (OIL.AX)?
What is the 5-year average ROE for Optiscan Imaging Limited (OIL.AX)?
How does the current ROE for Optiscan Imaging Limited (OIL.AX) compare to its historical average?